From chronic diseases, the climate crisis, to social injustice, how are we tackling the biggest problems of the 21st century? As UCL Business (UCLB) celebrates its 30th anniversary in 2023, this new monthly podcast series will explore how we have supported UCL academics to create impact across several areas, such as: medical research, patient healthcare, the environment, and our wellbeing in a contemporary society. New episodes will be released every third Thursday of each month. Soundtrack by Harry Penfold and Thomas Shearwood.
UCLB Big Talks on Big Impacts
Claim This Podcastby UCL Minds
5.0(2 reviews)
13 episodes
Updated Weekly
Accepts GuestsHas SponsorsLocation 🇬🇧
Podcast Overview
From chronic diseases, the climate crisis, to social injustice, how are we tackling the biggest problems of the 21st century? As UCL Business (UCLB) celebrates its 30th anniversary in 2023, this new monthly podcast series will explore how we have supported UCL academics to create impact across several areas, such as: medical research, patient healthcare, the environment, and our wellbeing in a contemporary society. New episodes will be released every third Thursday of each month. Soundtrack by Harry Penfold and Thomas Shearwood.
Language
🇺🇲
Publishing Since
1/18/2023
3 verified contact emails on file for UCLB Big Talks on Big Impacts
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
April 17, 2024
Professor Amit Nathwani’s journey to create a one-shot cure for haemophilia A
<p>To mark World Haemophilia Day, we sit down with Professor Amit Nathwani of the UCL Cancer Institute to explore his journey to commercialising the groundbreaking haemophilia A treatment, Roctavian. Host Nigel Campbell is joined by Prof Nathwani and Dr. Rick Fagan, UCLB Director of Biopharm, to explore how Amit’s work looking after patients with haemophilia in the NHS instilled a mission to develop a 'one and done' vaccine type approach to the condition. Amit’s lab to market story, working with UCLB, led to the creation of Roctavian, a one-time gene therapy used for the treatment of adults with severe haemophilia A. The therapy, which was licensed to BioMarin Pharmaceutical Inc, received marketing approval in Europe in 2022 and US FDA approval in 2023, and is now available to patients commercially.</p><p><br> Date of episode recording: 2024-04-10T00:00:00Z<br> Duration: 00:23:58<br> Language of episode: English<br> Presenter: Nigel Campbell<br> Guests: Prof Amit Nathwani; Dr Rick Fagan<br> Producer: Nora Amin</p><p>Visit out website for the transcript: https://www.uclb.com/ </p>
February 12, 2024
Positive Impact: A new generation of business with society at heart
<p>This episode we explore Positive Impact. UCLB is helping to create a new generation of businesses from UCL academics specifically with positive societal impact at their heart. The commercialisation process can be a long road requiring financial, legal, and practical support. Nigel Campbell meets two inventors, Buffy Price Co-founder and COO of Carbon Re, an AI and Climate Tech company spinout from UCL and Cambridge, and Professor Pete Coffey from UCL Institute of Ophthalmology and Founder of Tenpoint Therapeutics; both who are on that journey on how their inventions might improve our future world. We also talk to Dr Anne Lane, CEO of UCLB to find out how UCLB finds the bright ideas which will improve lives, and what it takes to scale to a point where they are having true impact.</p><p>Date of episode recording: 2024-02-06T00:00:00Z<br>Duration: 00:35:54<br>Language of episode: English<br>Presenter: Nigel Campbell<br>Guests: Anne Lane; Buffy Price; Prof Pete Coffey<br>Producer: Nora Amin<br> <br>For more information: https://www.uclb.com/podcasts/</p>
November 23, 2023
The financial synergy between research commercialisation and the university
<p>In this episode, Katy Bruce, CFO of UCL Business, and Charu Gorasia, CFO of UCL, will discuss the mutually beneficial relationship between the technology transfer office, such as UCLB, and the university. They will dive into the research income financial cycle and how the commercialisation income is distributed back into the research ecosystem. This podcast will also cover the challenges around commercialisation income, how to tackle these and what does the future hold.</p><p>For more information and to access the transcript: www.uclb.com/event-category/podcast/</p><p><br>Date of episode recording: 2023-10-11<br>Duration: 00:27:04<br>Language of episode: english<br>Presenter: Katy Bruce<br>Guests: Charu Gorasia<br>Producer: Nora Amin</p>
13 total episodes available
Deep-dive analytics for UCLB Big Talks on Big Impacts
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is UCLB Big Talks on Big Impacts?
- How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 10 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.